Background Orexigenic actions mediated by neuropeptide-Y (NPY) promote body weight regulation. Genetic variations in the NPY gene could therefore influence susceptibility to obesity, but results have been conflicting. We have carried out, for the first time, a case-control study to examine the effect of NPY rs16147 and rs5574 variants with the risk of obesity in Asians and also a meta-analysis to summarize the effect of these variants including that of the widely studied rs16139.
Genetic variations in the NPY gene could therefore influence susceptibility to obesity, but results have been conflicting. We have carried out, for the first time, a case-control study to examine the effect of NPY rs16147 and rs5574 variants with the risk of obesity in Asians and also a meta-analysis to summarize the effect of these variants including that of the widely studied rs16139.
Materials and methods
Genotypes and biochemistry data were determined for 942 children (262 cases and 680 controls) recruited from 23 randomly selected schools in Malaysia. Relevant articles were identified from Pubmed, Embase, Web of Science and Google Scholar. Data were extracted and summary estimates of the association between the NPY variants and obesity were examined.
Results
The frequency of the rs16147 T allele was significantly higher in the cases than controls (odds ratio 1.27, 95% confidence interval 1.04-1.55, P = 0.022), whereas the rs5574 T allele was significantly higher in the controls (odds ratio 0.76, 95% confidence interval 0.61-0.96, P = 0.020). In addition, NPY rs16147 was significantly correlated with obesity parameters including BMI, waist circumference, triglyceride and body fat percentage (P < 0.05). Meta-analysis including nine case-control studies further confirmed the findings of the association of the two variants with the risk of obesity and also found that rs16139 was associated with increased risk.
Conclusion This study suggests that NPY rs16147 T and rs16139 C minor alleles are associated with increased risk, whereas the minor allele T of the rs5574 is associated with a reduced risk of obesity. Pharmacogenetics and Genomics 25:501-510 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Obesity poses a serious socioeconomic and health-related burden worldwide [1] . It is an exaggeration of normal adiposity and may cause a broad range of health problems such as diabetes mellitus, hypertension and cardiovascular disease [2] [3] [4] . These health problems have traditionally been considered to affect adults, but it is now also found to affect younger age groups as a result of the increasing incidence of childhood obesity [5] . Genetic factor explains 40-70% of the interindividual variability in BMI, the most commonly used measure for obesity [6, 7] . In a recent large-scale genome-wide association study that involved more than 330 000 individuals, about 500 gene sets were significantly enriched for genes in BMI-associated loci, one of which is the neuropeptide-Y (NPY) gene that is mapped to the 7p15.1 chromosome in humans [8] .
NPY, a peptide derived from both the brain and sympathetic nerves, exerts its orexigenic activity following a carbohydrate-rich food intake [9] . This activity is mediated through NPY receptors. In the animal model of feeding behaviour, NPY reduces the latency to eat, increases motivation to eat and delays satiety [10] . Conversely, the absence of NPY through the knockdown of the NPY receptors promotes antiadipogenic, hence reducing abdominal obesity [11] . The NPY locus has also been discovered to be associated with nonalcoholic fatty liver disease, a hepatic manifestation of the metabolic syndrome [12] . Epidemiological studies have described the positive relationship between genetic variants of NPY and obesity [13, 14] .
Considerable attention has been focused on investigating the role of the functional NPY rs16139 (Leu7Pro) variant in obesity and obesity-related parameters. This variant Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.pharmacogeneticsandgenomics.com).
has also been linked to several conditions such as diabetes and cardiovascular disease [15] , as well as with progression of carotid atherosclerosis, increased blood pressure and elevated serum lipids [16] . Other important NPY variants that have been studied and could be functional are rs16147 and rs5574. The rs16147 is located on the promoter region, whereas rs5574 is located on exon 3 of the NPY gene. Both variants have been associated with early-onset atherosclerosis [17] and antipsychotic-induced weight gain in schizophrenia patients [18] . In addition, NPY rs16147 is reported to be associated with metabolic syndrome [19] , ischaemic stroke [20] , tobacco smoking and anxiety [21] . The association of the two variants with obesity is evidenced in several reports [14, 22, 23] . However, there are no data on the Asian population.
We carried out a case-control study to investigate the relationship between the two variants (rs16147 and rs5574) of the NPY gene and the risk of obesity. In addition, we aimed to carry out a meta-analysis to quantitatively assess the effect of both variants on the risk of obesity. The meta-analysis will also include the widely studied rs16139 variant. To our knowledge, a metaanalysis evaluating the relationships between these NPY variants and obesity has not been carried out previously, and the results of such evaluations could provide new insights into the relationships. ) and was converted into standardized z-scores, adjusted for sex and age on the basis of the International Obesity Task Force cut-off points [24] . Participants were categorized as overweight when BMI was between the 85th and the 95th percentile for age and sex and as obese when BMI more than 95th percentile for age and sex. Waist circumference was measured using an inelastic measuring tape to the nearest 0.1 cm at the umbilicus, between the 10th rib and the iliac crest, as per the WHO STEPS protocol [25] . Waist circumference was classified according to waist circumference percentile values for age and sex for Malaysian children [26] . Blood pressure was measured three times by the same examiner with participants sitting in a chair with the arm resting at the heart level. Blood samples were drawn and biochemical parameters such as glucose, insulin, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, triglyceride, aspartate transaminase enzyme, alanine aminotransferase enzyme and C-reactive protein were determined according to standard clinical laboratory methods carried out in an accredited laboratory at UMMC.
Materials and methods

Case-control
Measures of body fatness
Body fat percentage was measured using the validated portable body composition analyzer (Inbody 230; Biospace Co. Ltd, Seoul, Korea) as per the instruction manual.
Genotyping
Genomic DNA was extracted using the QiAamp DNA Mini Kit (Qiagen, Hilden, Germany) and the quality was checked to meet absorbance ratios of at least 1.8 for 260/280 and 260/230. The sample DNA was diluted to 10 and 20 ng/μl for the duplicate sample and placed in the well. Each amplification reaction contained 1 μl of DNA. The NPY rs16147 and rs5574 were genotyped at the University of Hong Kong, Genome Research Centre using the Sequenom MassARRAY technology platform with the iPLEX GOLD chemistry (Sequenom, San Diego, California, USA) according to the manufacturer's protocols. Briefly, the specific assays with proximal variants filtering were designed using the MassARRAY AssayDesign software package (v4.0; Sequenom). The quality of the PCR fragment amplification and extension primer specificity was checked before running the reaction. Residual nucleotides were dephosphorylated before the iPLEX Gold reaction. Following a single-base extension, reaction products were desalted with SpectroClean resin (Sequenom) and 10 nl was spotted onto the SpectroCHIP using the MassARRAY Nanodispenser. A MassARRAY Analyzer Compact MALDI-TOF mass spectrometer was used to determine the mass. For proper data acquisition and analysis, the MassARRAY Typer 4.0 software was used. Genotypes were called after cluster analysis using the default setting of a Gaussian mixture model. Cluster inspection was performed to ensure a clear cluster separation with a good signal to noise cut-off, followed by a manual review to further clarify uncertain genotype calls. An assay with less than an 80% call rate within the same SpectroChip was considered to have failed. Quality controls included a blank and five duplicates. SpectroChip with more than a 25% call rate in the blank control or with less than 99.5% concordance in duplicate checks along with more than a 10% call rate in blank check were considered to have failed and would be required to be repeated.
Statistical analysis
For the case-control study, genotype distribution was assessed for Hardy-Weinberg equilibrium (HWE) using the χ 2 -test. A P-value of more than 0.05 indicates an agreement with HWE. Before analysis, all variables were tested for normality using the Kolmogorov-Smirnov test. The demographic data between cases and controls were compared using the χ 2 -test. The clinical data between groups were assessed by analysis of using the general linear model. Comparisons of clinical data among genotypes were performed using a general linear model with sex and ethnicity as covariates. Genotype was coded as 0, 1 or 2 corresponding to the number of minor alleles carried by each individual. The association between the variants and the risk of obesity was evaluated using logistic regression derived from a log-additive genetic model. Linear regression for log-transformed variables, where appropriate, was performed to evaluate the correlation between the variant and obesity parameters. Statistical analyses were carried out using SPSS 22.0 (SPSS Inc., Chicago, Illinois, USA), with a two-sided P less than 0.05 considered as statistically significant. Linkage disequilibrium analysis was carried out using the Haploview 4.2 program (Broad Institute, Cambridge, Massachusetts, USA).
Meta-analysis Search strategy
A comprehensive search of medical databases including Pubmed, Embase, Web of Science and Google Scholar was performed to identify relevant studies, with the last update being on 25 March 2015. The search terms used were according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement [27] with the following keyword combinations: '(neuropeptide y or npy) and (snps or polymorphisms or genetic variants) and (obesity or BMI)'. References of retrieved articles, including review articles related to this topic, were also screened for potential articles that could have possibly been missed in the initial search. The search was also expanded to different terminologies used for the variants investigated: (rs16147 or − 399T > C) and (rs5574) and (rs16139 or + 1128T > C or Leu7Pro).
Inclusion and exclusion criteria
Only published articles that fulfilled the following inclusion criteria were included in this study: (i) full text published in English; (ii) obesity as the outcome of the study; (iii) evaluated the association between NPY rs16147/rs5574/rs16139 with obesity; (iv) case-control study; and (v) provided sufficient data with an odds ratio (OR) and 95% confidence intervals (CIs) under an additive model or at least allowed for calculation of this estimate. Studies that did not fulfil these criteria were excluded.
Data extraction and quality score assessment Data from eligible articles were extracted in duplicate by two independent authors using a standard protocol. The same two authors reviewed the titles and abstracts of potential articles to obtain valuable information. Full texts were retrieved when the relevance of the articles could not be determined by the title or abstract alone. In the event of conflict, disagreements were resolved through discussion among all authors and a consensus decision was reached. Corresponding authors of studies were contacted for missing data. Included studies were also subjected to quality assessment by the same two authors. The quality of observational studies, which included three aspects (selection, comparability and exposure), was evaluated using the Newcastle-Ottawa Scale (NOS) [28] . The NOS score ranges from 0 to 9, in which studies with a score of at least 7 were considered to be of high quality. Details of the PRISMA criteria used are available in Supplemental digital content 1 (http:// links.lww.com/FPC/A880) and 2 (http://links.lww.com/FPC/ A881), which provide the PRISMA checklist and flow diagram of the studies included.
Statistical analysis
The primary outcome of this meta-analysis was to assess the pooled ORs with 95% CIs to determine the strength of association. Allele frequencies were determined using the allele counting method, otherwise provided in the studies. HWE was checked for each study using the χ 2 -test and deviations were those with P less than 0.05. The following outcomes of interest were assessed from the OR of each individual study: additive (B vs. A), dominant (AB + BB vs. AA), recessive (BB vs. AA + AB), homozygote (BB vs. AA) and the heterozygote (AB vs. AA) genetic models of inheritance. The Mantel-Haenszel test was performed to estimate the pooled ORs and corresponding 95% CIs by assuming either a fixed-effect or a random-effect meta-analysis, where appropriate. Visual inspection of the forest plot was first carried out, followed by χ 2 -test of heterogeneity (a test of significance for heterogeneity) and inconsistency index I 2 (for the magnitude of heterogeneity). Heterogeneity was deemed when the χ 2 -test yielded a P-value of less than 0.10 and I 2 values more than 50%. A fixed-effect model was used in the presence of little or no heterogeneity; otherwise a random-effect model was adopted [29] . Begg's funnel plot asymmetry and Egger's correlation tests were used to evaluate the risk of publication bias [30, 31] . Subgroup analysis of different covariates was carried out in consideration of the influence of the covariates. The influence of each study in the pooled estimates was investigated in a sensitivity test. Meta-analysis was carried out using the Review Manager (RevMan 5.3; The Cochrane Collaboration, Copenhagen, Denmark) of the Cochrane Collaboration.
Results
Case-control Participants' characteristics
For the purpose of this study, 942 participants (28% male, 74% of Malay ethnic, 13% Chinese, 10% Indian and 3% others) were available for blood sampling and were considered eligible for inclusion in the study. In summary, 262 participants were classified as cases (overweight plus obese) and 680 were classified as controls. The baseline characteristics of the study participants are shown in Table 1 . Significantly higher levels of anthropometric parameters (weight, height, BMI, BMI z-score and waist circumference) as well as other metabolic and clinical parameters (low-density lipoprotein cholesterol, triglyceride, insulin, body fat percentage, systolic and diastolic blood pressure, alanine aminotransferase and C-reactive protein) were observed in the cases compared with the controls. High-density lipoprotein cholesterol levels were found to be significantly lower in the cases.
Association of NPY variants with obesity and obesityrelated parameters Table 2 shows the association analysis of NPY variants and the risk of obesity. Genotype distributions for each variant followed HWE. The frequency of the rs16147 T allele was significantly higher in the overweight plus the obese group compared with the C allele (P = 0.04) and remained significant following adjustment for sex and ethnicity (adjusted OR 1.46, 95% CI 1.02-2.07, P = 0.036). In contrast, the T allele frequency for rs5574 was significantly higher in the controls (adjusted OR 0.63, 95% CI 0.46-0.86, P = 0.02). Both variants were in strong linkage disequilibrium (D′ = 0.97). We further evaluated the association of the variants with obesityrelated parameters (Table 3) . We found that rs16147 homozygous TT was associated with increased levels of BMI, waist circumference, triglyceride and body fat percentage (P < 0.05); however, we observed no significant association of rs5574 with these parameters. To investigate the correlation between the rs16147 and these associated parameters, we carried out linear regression analyses of log-transformed variables. Analyses showed positive significant correlations between the rs16147 T allele and obesity parameters (P < 0.05), indicating an increased level of obesity parameters in those harbouring the T allele. These results thus support and suggest the significant impact of the NPY variants with obesity.
Meta-analysis Study characteristics
The study selection procedure is detailed in Fig. 1 . Overall, 84 articles met the search terms, of which 27 were considered potentially relevant and were subjected to a careful examination. After reading the full texts, 18 articles were subsequently excluded because of the reasons presented in Fig. 1 . Finally, four studies investigating the rs16147 [14, 22, 23] , two studies investigating the rs5574 [14] and six studies investigating the rs16139 [13, 14, [32] [33] [34] [35] were incorporated into the meta-analysis. Table 4 shows the characteristics of the studies. In the present study and eight other articles published between 1998 and 2015, the study size ranged from 263 to 3339, with a total of 8895 participants. The majority of the studies were carried out in Whites and involved adults [13, 14, 22, [33] [34] [35] , whereas there were only two studies in Asians [32] and involved children [23] . All of the studies scored well on quality assessment that includes selection criteria, comparability of cases and controls in terms of design and analysis, and availability of genetic data, except for Mutschler et al. [22] , which was of moderate quality (Supplemental digital content 3, http://links.lww.com/FPC/ A882, shows the assessment score for study quality).
Quantitative synthesis rs16147
Four case-control studies [14, 22, 23] from nine reports, involving a total of 5706 participants (1021 cases and 4685 controls), evaluated the association between rs16147 and obesity. Fixed-effect models were used in the analyses because of the absence of significant heterogeneity as assessed by the Q statistic (P > 0.10) and I 2 values (< 50%) for all genetic models. Meta-analysis of the pooled studies indicated a significant risk of obesity associated with rs16147 (OR 1.20, 95% CI 1.08-1.33, P = 0.0005) (Fig. 2) . Similarly, the association was observed in the pooled estimates when assuming alternative genetic models (Table 5) , except in the heterozygote. After stratification by ethnicity, significant associations were observed in Whites (OR 1.18, 95% CI 1.05-1.33, P = 0.006) [14, 22, 23] and Asians (OR 1.26, 95% CI 1.03-1.55, P = 0.02), with no difference observed in ORs. This association was also significant in children (OR 1.31, 95% CI 1.12-1.53, P = 0.007) [23] , but not in adults [14, 22] . The association was also not affected when we carried out analyses according to the NOS score.
rs5574
Only two studies [14] investigated the association between rs5574 and obesity, with a total of 4125 participants (626 cases and 3499 controls). Fixed-effect models were assumed for all genetic models. Unlike rs16147, the minor allele T of the rs5574 was associated with a reduced risk of obesity (OR 0.84, 95% CI 0.74-0.96, P = 0.008) (Fig. 2) . This significant association was replicated in all other genetic models, except for the recessive model (Table 5) . Meta-analysis of the relationship between rs16139 and the risk of obesity included six independent studies [13, 14, [32] [33] [34] [35] containing data from 6148 participants (1367 cases and 4781 controls). We adopted fixed-effect models in additive, dominant and heterozygote models. The recessive and homozygote models were not applied in the analysis due to the rare presence of Pro-allele in the populations that would not allow the overall estimation. Associations with risk of obesity were observed in the additive (OR 1.32, 95% CI 1.08-1.60, P = 0.006), dominant (OR 1.36, 95% CI 1.10-1.67, P = 0.004) and the heterozygote (OR 1.36, 95% CI 1.10-1.68, P = 0.004) models (Fig. 2 and Table 5 ). We also analysed the results in random-effect models as the Q statistic and I 2 values were moderate; analysis, however, confirmed our primary results (P < 0.01). The availability of data from various subgroups has enabled different comparisons. Results indicated a statistically significant association in both sexes (male: OR 2.32, 95% CI 1.33-4.06, P = 0.003, and female: OR 1.58, 95% CI 1.10-2.28, P = 0.01) [13, 14] and Whites (OR 1.49, 95% CI 1.20-1.86, P = 0.0003) [13, 14, [33] [34] [35] .
Sensitivity analysis
We carried out a sensitivity analysis by sequential removal of the included studies to assess the stability of the results. A slight quantitative alternation in the estimates was observed when we excluded the study by Yeung et al. [14] , although it did not affect the homogeneity of the studies. This could be because of the deviation from HWE observed in the study controls of Yeung et al. [14] . This deviation is likely because of the rare existence of the rs16139 risk allele. In addition, the Zain et al. [12] Zain et al. [12] Bhaskar et al. [32] Van Rossum et al. [13] Ding et al. [33] Mattevi et al. [35] Karvonen et al. [34] Mutschler et al. [22] Olza et al. [23] Yeung et al. [14] Yeung et al. [14] Yeung et al. [14] 1.1.1 rs16147
1.1.2 rs5574
rs16139
Association analyses between NPY variants and obesity. Estimations of odds ratios (OR) and 95% confidence intervals (CI) in each study are shown as closed squares and horizontal lines, respectively. The size of the black squares reflects the weight of the study in the meta-analysis. The diamond represents the combined OR, calculated using a fixed-effect model, with its 95% CI. M-H, Mantel-Haenszel; NPY, neuropeptide-Y. controls had a relatively lower risk allele in nature, as would have been expected, in contrast to the cases that are enriched for that risk allele.
Publication bias
No evidence of publication bias was observed across studies as indicated by the symmetry visual inspection of the funnel plot for all variants (Supplemental digital content 4, http://links.lww.com/FPC/A883, which shows a funnel plot of each variant under additive model). The subjective visual interpretation of the plot was overcome using Egger's test, which provided further supportive statistical evidence for the absence of significant publication bias (P >0.05).
Discussion
This case-control study evaluated the association between NPY gene variants (rs16147 and rs5574) with the risk of obesity in children from a multischool cohort study in Malaysia and found that the rs16147 T allele contributed towards an increased risk of obesity, whereas the rs5574 T-allele conferred reduced risk. The metaanalysis further explored these relationships and by summarizing the evidences from several independent studies, the results confirmed the association of both variants with obesity. In addition to the variants investigated, meta-analysis showed that rs16139 was also associated with increased susceptibility to obesity.
Evidence linking NPY rs16147 and rs5574 with obesity outcome has been reported in several studies, although this has not been studied extensively. Three studies reported the association of rs16147 with obesity [14, 22, 23] ; however, the results are incompatible. A study by Olza et al. [23] showed a significant association of rs16147 with obesity, but no significant association was reported by Yeung et al. [14] . Although Mutschler et al. [22] failed to identify a significant association of rs16147 with obesity, this variant was, however, found to be associated significantly with lower WHRs and higher serum leptin levels in women. In our case-control study, we replicated the results of Olza et al. [23] by showing a significant association of rs16147 with an increased risk of obesity. NPY rs16147 is a functional variant in which the C allele is associated with a decreased expression level of NPY [36] . As NPY stimulates fat growth, an increase in BMI is therefore expected with homozygosity for the T allele, a trend that was significantly observed in this study. Support for the finding that rs16147 as a risk variant for obesity comes from a study by Hohmann et al. [37] , in which the authors showed that carriers for the homozygote C allele show significantly lower BMI scores compared with noncarriers. This notion is further strengthened by our correlation models in which the rs16147 T allele was significantly correlated with increased levels of BMI, body fat percentage, waist circumference and triglyceride. As for rs5574, this variant is associated significantly with reduced risk of obesity and decreased levels of BMI in our study, but did not corroborate with the earlier report by Yeung et al. [14] , which found no significant association. In fact, we showed that rs5574 is in strong linkage disequilibrium with rs16147, which was supported by the finding of Yeung et al. [14] . In addition, haplotype TTCC inferred from four SNPs (rs17149106, rs16147, rs16139, and rs5574) appears to have twice the risk of obesity when compared to the common haplotype GCTT [14] .
Meta-analysis has been considered the best tool to summarize the findings from different independent studies into one estimate that could act as a representative value for overall findings and to overcome the limitation in sample size and statistical power [38] . To quantitatively examine the potential effect of both variants rs16147 and rs5574 with obesity, we carried out a metaanalysis on the basis of several case-control studies. Our pooled estimates showed that the rs16147 T allele was significantly associated with an increased risk of obesity, whereas a significantly reduced risk was observed for the rs5574 T allele. In addition, rs16147 was associated positively for dominant, recessive and homozygote models, and in the case of rs5574, it was associated for all genetic models. There also seemed to be a homogenous association of the rs16147 with the risk of obesity among Whites and Asians, with no difference in the observed ORs. Thus, the results of these meta-analyses further supported our case-control findings. This meta-analysis also included the rs16139, a widely studied variant of NPY, and its relationship with various metabolic conditions, including impaired glucose tolerance and type 2 diabetes [39] , hypertension [16] , as well as BMI changes [13, 33] . We could show that this variant is associated significantly with an increased risk of obesity. Subgroup analyses also indicated that there was no variation in the results when interpreted in a different set of comparisons, indicating a robust estimate without other contributing factors.
Nonetheless, the findings from the present meta-analysis should be interpreted within the context of several limitations. First, the relatively small number of included studies, particularly for the rs16147 and rs5574, may affect the precision of the overall estimates and subsequently the results of the subgroup comparisons. Second, different studies used different sets of BMI ranges to define the obese group from the controls and may thus affect the actual findings. For example, three studies [14, 22, 33] 2 . Third, most of the studies were carried out on Whites; thus, the results from the Asian studies would not have truly represented the Asians, given that the effective allele frequency between Asians and Whites varies. Fourth, the overall outcomes were estimated on the basis of case-control studies without adjustments. A nested case-control design that is matched by age, sex and ethnicity from multiethnic prospective studies appears to be an optimal design to assess the relationship between NPY variants and obesity. Fifth, detailed information such as sex is not easily obtainable from published studies, therefore limiting the sex comparison. Nonetheless, our meta-analysis has some strengths. The results of this meta-analysis support most of the previously reported studies of a significant association between NPY variants and obesity. The homogeneity among studies has enabled the conclusion to be drawn with more confidence. Furthermore, we explored the relationship between these variants and obesity in different genetic models.
In conclusion, we present the first report in an Asian population and confirmed the association of NPY rs16147 and rs5574 with obesity. Our meta-analysis further supports the results for these variants and also showed that a nonsynonymous variant rs16139 is associated with an increased risk of obesity. To our knowledge, this is the first meta-analysis to provide evidence of an association between NPY variants and obesity. Further studies with a larger sample size in diverse populations are required to further confirm this association. In light of this finding, it is also important to determine the role of other variants that are in close proximity to these investigated variants.
